Developer docs
API playgroundTry for free, no card

Search company profiles

University of California San Diego School of Medicine

Full company profile

uuid0002e2x

Namestring
University of California San Diego School of Medicine
Legal namestring
University of California San Diego School of Medicine
Company typeenum
Private
Founded yearint
1970
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersSan Diego, United States
HQ citystring
San Diego
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical education, biomedical research, patient care, physician training, academic medicine
NAICS code2 codes
  • Colleges, Universities, and Professional Schools6113
  • General Medical and Surgical Hospitals62211
SIC code3 codes
  • Services-Hospitals8060
  • Services-General Medical & Surgical Hospitals, Nec8062
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Medical Education
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Tuition and Fees
TypeSubscription Recurring
Description

Medical school tuition and fees from MD, PA, graduate, residency, and fellowship programs. Fully LCME accredited institution with next accreditation visit April 2026.

medschool.ucsd.edu
2Philanthropic Donations
TypeOne Time License
Description

Charitable gifts from donors supporting scholarships, research, surgical advancement, and medical innovation programs. Recent $5 million gift from Joseph and Honmai Goodman for surgical advancement and medical innovation.

sdbn.org
3Research Grants and Contracts
TypeSubscription Recurring
Description

Federal and private research funding including NIH, CDC, and foundation grants. Maintained a $653 million portfolio of contracts and grants in 2025 despite challenging federal research funding environment.

today.ucsd.edu
4Patient Care Revenue
TypeTransaction Fee
Description

Clinical care services provided through UC San Diego Health system including UC San Diego Medical Center in Hillcrest, Jacobs Medical Center in La Jolla, and various outpatient clinics and mobile health clinics.

medschool.ucsd.edu
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 3 records shown
1Precision Medicine Therapeutics in Oncology (PMTO)
Description

Master of Advanced Studies program designed to train healthcare providers, researchers, and life sciences professionals in developing and delivering personalized cancer treatments

oncodaily.com
+2 more records
Core offering1 text field

UC San Diego School of Medicine is a public academic medical institution that delivers medical education, biomedical research, and patient care. It offers MD and combined degree programs, graduate programs in MS and PhD, residency and fellowship training, the Atkinson Physician Assistant Education Program, and the Precision Medicine Therapeutics in Oncology graduate program. Clinical care is delivered through UC San Diego Health teaching hospitals in La Jolla and Hillcrest, supplemented by mobile health clinics serving San Diego County communities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 72% of anorexia nervosa patients in ketogenic intervention study no longer met diagnostic criteria after 14 weeks
+4 more records
Product overview1 text field

UC San Diego School of Medicine offers a comprehensive portfolio of medical education programs and services organized as a platform-plus-modules architecture. The core offerings include MD and combined degree programs (MD/PhD, MSTP, PRIME, CIMAC, GHAC), graduate programs, residency and fellowship training, and a Physician Assistant program. Supporting infrastructure includes the iPad Learning Initiative (Triton MedTech) providing students with technology tools, the Simulation Training Center for procedural skills practice, and the Health Sciences Office of Faculty Affairs offering faculty development programs. The school also operates the Precision Medicine Therapeutics in Oncology (PMTO) graduate program and maintains a $653 million portfolio of research contracts and grants, with Pivot Grants supporting researchers during funding disruptions.

Product and service7 records
1Triton MedTech iPad Learning Initiative
CategoryMedical Education Technology
Description

A technology-enhanced medical education program providing all incoming medical students with iPad Air, Apple Pencil, and Apple Care+ for the duration of their education, integrating technology into the curriculum with educational apps including Complete Anatomy for 3D anatomy studies. 98% of surveyed students agreed having an iPad positively influenced their education.

2Simulation Training Center
CategoryMedical Training Facility
Description

A training facility supporting professional development and patient safety by providing opportunities for the learning and practice of procedural skills with high-fidelity patient simulators (manikins) and partial task trainers, open to medical students, residents, and fellows.

3Precision Medicine Therapeutics in Oncology (PMTO) Program
CategoryGraduate Degree Program
Description

A Master of Advanced Studies graduate degree program designed to train healthcare providers, researchers, and life sciences professionals in developing and delivering personalized cancer treatments. The interdisciplinary program addresses the gap where fewer than 1 in 20 cancer patients receive precision oncology treatments despite nearly 100 such therapies being approved.

4Health Sciences Office of Faculty Affairs Programs
CategoryFaculty Development
Description

Evidence-based programming to support faculty success including Faculty Development programs (FMTP mentorship training, FOCUS cardiovascular sciences, GWC grant writing, LAUNCH neurosciences, NCLAM junior faculty, RAPID infectious diseases), Faculty Engagement initiatives, and Climate & Demographics assessments.

5Atkinson Physician Assistant Education Program
CategoryMedical Degree Program
Description

A two-year Physician Assistant Education Program training graduates to provide safe, effective, person-centered healthcare, with inaugural class of 30 students beginning June 2024.

6Pivot Grants Program
CategoryResearch Funding Program
Description

A grant program launched in partnership with the Prebys Foundation to support researchers in transitioning their work to sustainable areas amid federal research funding disruptions, providing $1 million in funding to 19 researchers.

7Human Milk Institute Research Consortium
CategoryResearch Consortium
Description

Research consortium at the Human Milk Institute established in partnership with Novonesis, providing startup funding for five interconnected seed grants to advance Human Milk Oligosaccharides (HMOs) and synbiotics research.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
1San Diego Alzheimer's Project
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-05-04
Description

Since the dementia detection study's completion, the San Diego Alzheimer's Project has helped five San Diego health systems adopt EMR-integrated standards for cognitive screening and evaluation.

health.ucsd.edu
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-30
Description

External dataset used to validate T1GRS machine learning model for Type 1 Diabetes genetic risk prediction, along with nPOD biobank.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-30
Description

External dataset used to validate T1GRS machine learning model for Type 1 Diabetes genetic risk prediction, achieving 87% accuracy and generalizable sub-type classifications.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-04-24
Description

Co-lead institution with UC San Diego School of Medicine on study analyzing National Survey on Drug Use and Health data, finding approximately 8 million Americans used psilocybin in 2024.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-06-26
Description

Researchers from Weill Cornell Medicine and UC San Diego propose adopting learning health systems principles in academic medical centers to improve patient care through real-time data analysis from electronic health records and hospital operations, with AI playing a key role.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-21
Description

Collaboration on MDL-001, an oral broad-spectrum antiviral candidate with preclinical efficacy against four viral families, seven viruses, and 13 variants/strains including SARS-CoV-2, influenza, norovirus, and hepatitis C. Model Medicines also announced the ViroMME program under the Model Medicines Endeavor initiative to advance the infectious disease pipeline.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-21
Description

Research collaboration with Model Medicines and UC San Diego researchers publishing preprint on MDL-001 broad-spectrum antiviral candidate. The three-institution partnership brings together academic and industry researchers for infectious disease drug development.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

CDC selected UC San Diego as one of three partner institutions to establish a groundbreaking pandemic preparedness initiative, with UCSD leading the data hub of the CDC-funded pandemic preparedness network.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-08-01
Description

Community partner for mobile health clinics (general health and mammography) bringing essential healthcare directly to communities across San Diego County. Mobile clinics reached more than 300 individuals across 12 community events since launching in August 2024.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-08-01
Description

Community partner for mobile health clinics providing healthcare access to underserved communities across San Diego County through community events, reaching over 300 individuals since the program launched.

11Many Shades of Pink
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2024-08-01
Description

Community partner for mobile health clinics specifically focused on breast health and mammography services, contributing to the program's reach of 300+ individuals across 12 community events.

medschool.ucsd.edu
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-03-19
Description

Global biosolutions leader providing startup funding for five interconnected seed grants establishing a research consortium at the Human Milk Institute. Novonesis is also providing HMOs and probiotics for the research. Shared vision to revolutionize Human Milk Oligosaccharides (HMOs) and synbiotics research, combining Novonesis's industry capabilities with UC San Diego's academic research excellence.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-01-01
Description

Regional Hubs of Healthcare Opportunity led by four UC medical schools (UCR, UC Davis, UC San Diego, and UCSF-Fresno) following Senate Bill 40 in 2021. 399 students enrolled since 2022-2023 with 150 transferring to four-year universities in 2023-2024. Addresses California's physician shortage by creating a pathway from community college to medical school for underrepresented and first-generation students.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

University of California San Diego School of Medicine

Medical Educationmedschool.ucsd.edu

University of California San Diego School of Medicine firmographics

Firmographics
Name
University of California San Diego School of Medicine
Legal name
University of California San Diego School of Medicine
Website
https://medschool.ucsd.edu
Company type
Private
Founded year
1970
Operating status
Operating
Headcount range
1,001–5,000 employees
Ownership category
akta.pro rank

Where University of California San Diego School of Medicine is headquartered

Location

Headquarters

HQ city
San Diego
HQ country
United States
HQ region
North America

Offices5 records

Markets served

University of California San Diego School of Medicine business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Tuition and Fees: Medical school tuition and fees from MD, PA, graduate, residency, and fellowship programs. Fully LCME accredited institution with next accreditation visit April 2026.
  2. Philanthropic Donations: Charitable gifts from donors supporting scholarships, research, surgical advancement, and medical innovation programs. Recent $5 million gift from Joseph and Honmai Goodman for surgical advancement and medical innovation.
  3. Research Grants and Contracts: Federal and private research funding including NIH, CDC, and foundation grants. Maintained a $653 million portfolio of contracts and grants in 2025 despite challenging federal research funding environment.
  4. Patient Care Revenue: Clinical care services provided through UC San Diego Health system including UC San Diego Medical Center in Hillcrest, Jacobs Medical Center in La Jolla, and various outpatient clinics and mobile health clinics.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

University of California San Diego School of Medicine product offering

Product offering

Core offering

UC San Diego School of Medicine is a public academic medical institution that delivers medical education, biomedical research, and patient care. It offers MD and combined degree programs, graduate programs in MS and PhD, residency and fellowship training, the Atkinson Physician Assistant Education Program, and the Precision Medicine Therapeutics in Oncology graduate program. Clinical care is delivered through UC San Diego Health teaching hospitals in La Jolla and Hillcrest, supplemented by mobile health clinics serving San Diego County communities.

Product overview

UC San Diego School of Medicine offers a comprehensive portfolio of medical education programs and services organized as a platform-plus-modules architecture. The core offerings include MD and combined degree programs (MD/PhD, MSTP, PRIME, CIMAC, GHAC), graduate programs, residency and fellowship training, and a Physician Assistant program. Supporting infrastructure includes the iPad Learning Initiative (Triton MedTech) providing students with technology tools, the Simulation Training Center for procedural skills practice, and the Health Sciences Office of Faculty Affairs offering faculty development programs. The school also operates the Precision Medicine Therapeutics in Oncology (PMTO) graduate program and maintains a $653 million portfolio of research contracts and grants, with Pivot Grants supporting researchers during funding disruptions.

Differentiator

Problem solved

Functional benefit

Brands

  • Precision Medicine Therapeutics in Oncology (PMTO): Master of Advanced Studies program designed to train healthcare providers, researchers, and life sciences professionals in developing and delivering personalized cancer treatments
  • Atkinson Physician Assistant Education Program
  • Viterbi Family Vision Research Center

Products and services

  • Triton MedTech iPad Learning Initiative A technology-enhanced medical education program providing all incoming medical students with iPad Air, Apple Pencil, and Apple Care+ for the duration of their education, integrating technology into the curriculum with educational apps including Complete Anatomy for 3D anatomy studies. 98% of surveyed students agreed having an iPad positively influenced their education.
  • Simulation Training Center A training facility supporting professional development and patient safety by providing opportunities for the learning and practice of procedural skills with high-fidelity patient simulators (manikins) and partial task trainers, open to medical students, residents, and fellows.
  • Precision Medicine Therapeutics in Oncology (PMTO) Program A Master of Advanced Studies graduate degree program designed to train healthcare providers, researchers, and life sciences professionals in developing and delivering personalized cancer treatments. The interdisciplinary program addresses the gap where fewer than 1 in 20 cancer patients receive precision oncology treatments despite nearly 100 such therapies being approved.
  • Health Sciences Office of Faculty Affairs Programs Evidence-based programming to support faculty success including Faculty Development programs (FMTP mentorship training, FOCUS cardiovascular sciences, GWC grant writing, LAUNCH neurosciences, NCLAM junior faculty, RAPID infectious diseases), Faculty Engagement initiatives, and Climate & Demographics assessments.
  • Atkinson Physician Assistant Education Program A two-year Physician Assistant Education Program training graduates to provide safe, effective, person-centered healthcare, with inaugural class of 30 students beginning June 2024.
  • Pivot Grants Program A grant program launched in partnership with the Prebys Foundation to support researchers in transitioning their work to sustainable areas amid federal research funding disruptions, providing $1 million in funding to 19 researchers.
  • Human Milk Institute Research Consortium Research consortium at the Human Milk Institute established in partnership with Novonesis, providing startup funding for five interconnected seed grants to advance Human Milk Oligosaccharides (HMOs) and synbiotics research.

Quantifiable outcome

  • 72% of anorexia nervosa patients in ketogenic intervention study no longer met diagnostic criteria after 14 weeks
  • +4 more outcomes

Companies that use University of California San Diego School of Medicine

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles5 records

University of California San Diego School of Medicine technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

University of California San Diego School of Medicine partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered minor and core.

  • San Diego Alzheimer's ProjectminorStrategic or Co-development Partner · 4 May 2026Since the dementia detection study's completion, the San Diego Alzheimer's Project has helped five San Diego health systems adopt EMR-integrated standards for cognitive screening and evaluation.
  • NIH All of Us Research ProgramminorStrategic or Co-development Partner · 30 April 2026External dataset used to validate T1GRS machine learning model for Type 1 Diabetes genetic risk prediction, along with nPOD biobank.
  • nPOD BiobankminorStrategic or Co-development Partner · 30 April 2026External dataset used to validate T1GRS machine learning model for Type 1 Diabetes genetic risk prediction, achieving 87% accuracy and generalizable sub-type classifications.
  • New York UniversityminorStrategic or Co-development Partner · 24 April 2026Co-lead institution with UC San Diego School of Medicine on study analyzing National Survey on Drug Use and Health data, finding approximately 8 million Americans used psilocybin in 2024.
  • Weill Cornell MedicineminorStrategic or Co-development Partner · 26 June 2025Researchers from Weill Cornell Medicine and UC San Diego propose adopting learning health systems principles in academic medical centers to improve patient care through real-time data analysis from electronic health records and hospital operations, with AI playing a key role.
  • Model MedicinescoreStrategic or Co-development Partner · 21 January 2025Collaboration on MDL-001, an oral broad-spectrum antiviral candidate with preclinical efficacy against four viral families, seven viruses, and 13 variants/strains including SARS-CoV-2, influenza, norovirus, and hepatitis C. Model Medicines also announced the ViroMME program under the Model Medicines Endeavor initiative to advance the infectious disease pipeline.
  • Icahn School of Medicine at Mount SinaicoreStrategic or Co-development Partner · 21 January 2025Research collaboration with Model Medicines and UC San Diego researchers publishing preprint on MDL-001 broad-spectrum antiviral candidate. The three-institution partnership brings together academic and industry researchers for infectious disease drug development.
  • CDC (Centers for Disease Control and Prevention)coreStrategic or Co-development Partner · 1 January 2025CDC selected UC San Diego as one of three partner institutions to establish a groundbreaking pandemic preparedness initiative, with UCSD leading the data hub of the CDC-funded pandemic preparedness network.
  • Haitian Bridge AllianceminorStrategic or Co-development Partner · 1 August 2024Community partner for mobile health clinics (general health and mammography) bringing essential healthcare directly to communities across San Diego County. Mobile clinics reached more than 300 individuals across 12 community events since launching in August 2024.
  • Ventanilla de SaludminorStrategic or Co-development Partner · 1 August 2024Community partner for mobile health clinics providing healthcare access to underserved communities across San Diego County through community events, reaching over 300 individuals since the program launched.
  • Many Shades of PinkminorStrategic or Co-development Partner · 1 August 2024Community partner for mobile health clinics specifically focused on breast health and mammography services, contributing to the program's reach of 300+ individuals across 12 community events.
  • NovonesiscoreStrategic or Co-development Partner · 19 March 2024Global biosolutions leader providing startup funding for five interconnected seed grants establishing a research consortium at the Human Milk Institute. Novonesis is also providing HMOs and probiotics for the research. Shared vision to revolutionize Human Milk Oligosaccharides (HMOs) and synbiotics research, combining Novonesis's industry capabilities with UC San Diego's academic research excellence.
  • California Medicine Scholars Program (UC R, UC Davis, UCSF-Fresno)coreStrategic or Co-development Partner · 1 January 2021Regional Hubs of Healthcare Opportunity led by four UC medical schools (UCR, UC Davis, UC San Diego, and UCSF-Fresno) following Senate Bill 40 in 2021. 399 students enrolled since 2022-2023 with 150 transferring to four-year universities in 2023-2024. Addresses California's physician shortage by creating a pathway from community college to medical school for underrepresented and first-generation students.

Scale indicators14 records

Recent moves9 records

Expansion highlights7 records

University of California San Diego School of Medicine competitors and assessment

Company assessment

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Customer concentration

University of California San Diego School of Medicine social profiles

Digital presence

University of California San Diego School of Medicine compliance and trust

Trust signal

Compliance1 record

University of California San Diego School of Medicine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

University of California San Diego School of Medicine leadership team

Management profile

Number of profiles

Profiles9 records

University of California San Diego School of Medicine funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

University of California San Diego School of Medicine M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University of California San Diego School of Medicine

What does University of California San Diego School of Medicine do?

UC San Diego School of Medicine is a public academic medical institution that delivers medical education, biomedical research, and patient care. It offers MD and combined degree programs, graduate programs in MS and PhD, residency and fellowship training, the Atkinson Physician Assistant Education Program, and the Precision Medicine Therapeutics in Oncology graduate program. Clinical care is delivered through UC San Diego Health teaching hospitals in La Jolla and Hillcrest, supplemented by mobile health clinics serving San Diego County communities.

Is University of California San Diego School of Medicine a public or private company?

University of California San Diego School of Medicine is a private company. It is classified as state government owned and is currently operating.

When was University of California San Diego School of Medicine founded?

University of California San Diego School of Medicine was founded in 1970. It employs 1,001 to 5,000 people.

Where is University of California San Diego School of Medicine based?

University of California San Diego School of Medicine is headquartered in San Diego, United States, in the North America region.

How does University of California San Diego School of Medicine make money?

Four revenue lines are on record. Tuition and Fees are the primary driver. The others are philanthropic Donations, research Grants and Contracts and patient Care Revenue.

Does University of California San Diego School of Medicine have an API?

No public API is recorded for University of California San Diego School of Medicine.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Inc.Scientists Just Discovered a New Brain Phase Between 50 and 75. It May Help Explain Cognitive DeclineResearchers at the University of California, San Diego School of Medicine discovered a new biological phase in the brain that occurs between the ages of 50 and 75, as they studied single cells from human hippocampal tissue. This study reveals that brain aging involves an active overhaul of immune, vascular, and neuronal components rather than a steady decline, offering potential targets for future treatments. The findings contribute to a deeper understanding of cognitive decline and the aging process.Mirage NewsMindfulness Therapy for Opioid Misuse Yields Big ROIA new economic evaluation from the University of California San Diego School of Medicine has found that Mindfulness-Oriented Recovery Enhancement (MORE) therapy for opioid misuse provides $12 in cost savings for every dollar spent, generating lifetime cost savings of more than $324,000 per patient. The analysis, based on data from a randomized clinical trial of 250 adults with chronic pain who were misusing prescribed opioids, found the therapy two to six times more cost-effective than other addiction treatments such as residential or intensive outpatient programs. The researchers suggest that if widely implemented, MORE could provide a scalable, cost-effective solution for the U.S. opioid crisis, which currently costs up to $4 trillion per year in healthcare, criminal justice, and lost productivity expenses.American City Business JournalsSLU among 5 medical schools targeted in Trump admin DEI probeThe U.S. Department of Education's Office for Civil Rights launched investigations on Tuesday into five medical schools—Saint Louis University School of Medicine, Geisel School of Medicine at Dartmouth, Brody School of Medicine at East Carolina University, Western University of Health Sciences, and William Carey University College of Osteopathic Medicine—to determine whether their admissions practices violate Title VI of the Civil Rights Act of 1964 by engaging in racial discrimination. The investigations follow President Donald Trump's January 2025 executive order directing federal agencies to eliminate DEI ideology and ensure transparency in admissions processes at institutions of higher education. The Justice Department simultaneously announced that the University of California San Diego Medical School has been denying admission to white and Asian applicants in favor of lower-credential Black and Hispanic applicants.AfrotechUS Department Of Justice Accuses University Of California San Diego School Of Medicine Of Considering Race In Admissions - AfroTech | AfroTechThe U.S. Department of Justice's Civil Rights Division has found that the University of California San Diego School of Medicine violated Title VI of the Civil Rights Act of 1964 by considering race in its admissions process, contrary to Supreme Court rulings on race-conscious admissions. The DOJ alleges that admissions staff used subjective criteria to increase admission of "underrepresented minorities in medicine," resulting in more white and Asian applicants being denied admission compared to Black and Hispanic applicants. The department is currently working with the school to bring it into compliance and has warned it will file a lawsuit if those efforts fail.New York PostThe right Rx for UC med schools is not illegal racial discriminationThe author argues that the University of California San Diego School of Medicine has been accused by the US Department of Justice of illegally discriminating against student applicants based on race, using proxy data to determine applicants' race and favoring black and Hispanic applicants over whites and Asians. Federal probes have also led to similar allegations against the med schools of UCLA and UC Davis, with the DOJ warning it could file federal lawsuits if the schools do not voluntarily comply with the law. The author contends this violates California Proposition 209, which outlawed race-based preferences in 1996, as well as a 2023 US Supreme Court ruling that such practices are unconstitutional.BeckershospitalreviewJustice department finds 2 more medical schools discriminated based on raceThe Justice Department found that University of California San Diego School of Medicine and University of California, Davis School of Medicine discriminated based on race in their admissions processes, using "race-neutral" socioeconomic criteria as proxies to favor Black and Hispanic applicants. UC San Diego was investigated after using hardship application questions to identify underrepresented minority applicants, while UC Davis admitted Black and Hispanic applicants at rates up to six times higher than whites and Asians despite lower average qualifications. The DOJ has opened new investigations into 15 additional medical schools following the Supreme Court's 2023 ruling that affirmative action policies were unconstitutional.YahooDOJ: UC San Diego Med's admissions favor Black, Hispanic applicantsThe Justice Department found that the University of California San Diego School of Medicine unlawfully used race in its admissions process, favoring Black and Hispanic applicants over White and Asian applicants, in violation of Title VI of the Civil Rights Act. According to the DOJ's 2025 admissions data, Black applicants were admitted at 5.14% compared to nearly 2% for White applicants. The announcement comes as the Trump administration continues cracking down on race-conscious admissions at medical schools, following similar findings against UC Davis last month.New York PostUC San Diego School of Medicine used race in admissions to favor black and Hispanic applicantsThe Department of Justice found that the University of California San Diego School of Medicine violated federal law by using a "shadow application process" that relied on "hardship" questions as a racial proxy to favor black and Hispanic applicants over white and Asian applicants. The investigation, begun in March, revealed that black and Hispanic admitted students had significantly lower GPA and test score requirements (3.1 GPA and average scores) compared to white and Asian applicants (3.50 GPA and 83rd percentile or higher). The DOJ has demanded the school change its admissions practices and reach a settlement, or face a federal lawsuit.DevdiscourseDOJ Investigates UC San Diego Med School's Admissions PracticesThe U.S. Department of Justice has accused the University of California San Diego School of Medicine of biased admissions practices favoring Black and Hispanic applicants. This action is part of the Trump administration's broader effort to challenge diversity policies in educational institutions. UC San Diego maintains its commitment to federal law compliance, insisting academic thresholds are uniformly applied.MorningstarAnatomage Inc. Announces Recipients of the 2026 Anatomage Teacher AwardsAnatomage Inc. announced the 2026 Teacher Awards recipients, including Christopher White, Brian Spence, Jennifer Savage Burgett, and Amir Meraban. Each winner receives a $1,000 cash prize, a trophy, certificate, and free conference registration. The awards recognize educators using Anatomage technology to enhance anatomy and science education.